SCHEMBL1089853

SCHEMBL1089853

c1ccc2c(c1)CCN(c1nc(NCCN3CCCC3)nc3ccccc13)C2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MRGPRX1 Q96LB2 1/20 0.51
▸ GBA1 P04062 1/20 0.48
▸ HRH3 Q9Y5N1 3/20 0.47
▸ GRIN2D O15399 1/20 0.47
▸ GRIN3B O60391 1/20 0.47
▸ GRIN1 Q05586 1/20 0.47
▸ GRIN2A Q12879 1/20 0.47
▸ GRIN2B Q13224 1/20 0.47
▸ GRIN2C Q14957 1/20 0.47
▸ GRIN3A Q8TCU5 1/20 0.47
▸ TOP2A P11388 1/20 0.47
▸ ACP1 P24666 3/20 0.46
▸ SMARCA2 P51531 1/20 0.46
▸ ADRA2A P08913 1/20 0.43
▸ ADRA2B P18089 1/20 0.43
▸ ADRA2C P18825 1/20 0.43
▸ KDM6B O15054 2/20 0.43
▸ ADAMTS4 O75173 1/20 0.43
▸ TUBB4A P04350 1/20 0.42
▸ TUBB P07437 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1089123 0.99 MRGPRX1 (0.50) MRGPRX1GBA1HRH3GRIN2DGRIN3B
SCHEMBL1091393 0.94 HRH3 (0.54) MRGPRX1GBA1HRH3GRIN2DGRIN3B
SCHEMBL1091992 0.91 KMT2A (0.52) GBA1TOP2AACP1
SCHEMBL1090124 0.86 MRGPRX1 (0.65) MRGPRX1HRH3TOP2AACP1SMARCA2
SCHEMBL1089640 0.85 MRGPRX1 (0.64) MRGPRX1HRH3TOP2AACP1SMARCA2
SCHEMBL1090823 0.85 MRGPRX1 (0.64) MRGPRX1HRH3TOP2AACP1SMARCA2
SCHEMBL1089901 0.85 MRGPRX1 (0.64) MRGPRX1HRH3TOP2AACP1SMARCA2
SCHEMBL1088912 0.85 MRGPRX1 (0.64) MRGPRX1HRH3TOP2AACP1SMARCA2
SCHEMBL1088654 0.85 MRGPRX1 (0.64) MRGPRX1HRH3TOP2AACP1SMARCA2
SCHEMBL1089359 0.85 MRGPRX1 (0.64) MRGPRX1HRH3TOP2AACP1SMARCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 — — US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 — — US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 — — US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 — — US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 — — US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 MRGPRX1 237/4885GBA1 3584/4885HRH3 94/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 MRGPRX1 237/4885GBA1 3584/4885HRH3 94/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 MRGPRX1 237/4885GBA1 3584/4885HRH3 94/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback